Signaturefd, LLC Cti Biopharma Corp Transaction History

Signaturefd, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$4.2 - $6.01 $336 - $480	-80 Reduced 41.03%	115 $0
Q4 2022 Jan 27, 2023	SELL	$4.45 - $6.17 $1,993 - $2,764	-448 Reduced 69.67%	195 $1,000
Q3 2022 Nov 08, 2022	SELL	$5.36 - $7.43 $53 - $74	-10 Reduced 1.53%	643 $4,000
Q2 2022 Aug 10, 2022	BUY	$3.55 - $6.27 $2,318 - $4,094	653 New	653 $4,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.